Jim Buck, President, CEO & Director, leveraging 30 years of experience successfully developing and commercializing innovative medical technologies. While holding a Board Director position at Medcura since 2018, Jim also served as the President and CEO of cancer imaging innovator ClearCut Medical. Prior to ClearCut, Jim was President and CEO of American Heart Association award-winning heart valve therapy developer, Mardil Medical. One particularly relevant experience Jim brings to Medcura is from Closure Medical, where he was VP of Marketing & Business Development at one of the biosurgical industry’s most successful new technology companies. There, Jim directed the product-mapping strategy and execution for a novel surgical sealant and adhesive technology that was acquired by global healthcare leader, Johnson & Johnson, for more than $370 million. He also served in multiple management and executive roles at cardiac medical device leader St. Jude Medical, Inc., for more than a decade after earning a master’s degree in business from Northwestern University, and an undergraduate degree from Indiana University.